Form 4: BioLife Solutions Exec Sells Shares for Tax Obligations

BioLife Solutions' Chief Quality and Operations, Karen A. Foster, sold 335 shares of common stock to cover tax withholding obligations.

Summary

• Karen A. Foster, Chief Quality and Operations at BIOLIFE SOLUTIONS INC (BLFS), reported a sale of common stock.
• The transaction involved the disposition of 335 shares of common stock.
• The shares were sold at a price of $25.59 per share.
• The sale occurred on January 6, 2026.
• Following this transaction, Karen A. Foster beneficially owns 191,984 shares of common stock.
• The sale was executed pursuant to a Rule 10b5-1(c) trading plan, which was adopted on January 3, 2023.
• The purpose of the sale was to satisfy tax withholding obligations related to the vesting of restricted stock.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction for tax purposes, which is neutral in sentiment and does not indicate positive or negative company performance.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This insider transaction is a routine event for publicly traded companies, often occurring when executives' restricted stock vests and shares are sold to cover associated tax liabilities. It does not reflect broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: Minimal impact as this is a routine, pre-planned transaction for tax purposes and does not signal a change in management's confidence or company fundamentals.

Key Dates

Recommendation

The reported insider sale by Karen A. Foster is a routine transaction executed under a Rule 10b5-1 plan to cover tax withholding obligations from restricted stock vesting. Such sales are common and generally do not reflect a change in the executive's outlook on the company's prospects or warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate, maintaining the existing investment stance.

Keywords

BIOLIFE SOLUTIONS, BLFS, Form 4, Insider Transaction, Stock Sale, Executive Compensation, Tax Withholding, 10b5-1 Plan